000 01472 a2200421 4500
005 20250515071053.0
264 0 _c20070924
008 200709s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/j.bmcl.2007.04.099
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKai, Hiroyuki
245 0 0 _a2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 2: orally bioavailable compounds.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cJul 2007
300 _a3925-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aBiological Availability
650 0 4 _aCannabinoid Receptor Agonists
650 0 4 _aThiazines
_xadministration & dosage
700 1 _aMorioka, Yasuhide
700 1 _aTomida, Minoru
700 1 _aTakahashi, Tadashi
700 1 _aHattori, Maki
700 1 _aHanasaki, Kohji
700 1 _aKoike, Katsumi
700 1 _aChiba, Hiroki
700 1 _aShinohara, Shunji
700 1 _aKanemasa, Toshiyuki
700 1 _aIwamoto, Yuka
700 1 _aTakahashi, Kohji
700 1 _aYamaguchi, Yoshitaka
700 1 _aBaba, Takahiko
700 1 _aYoshikawa, Takayoshi
700 1 _aTakenaka, Hideyuki
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 17
_gno. 14
_gp. 3925-9
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2007.04.099
_zAvailable from publisher's website
999 _c17071962
_d17071962